ES8500056A1 - Procedimiento para la preparacion de derivados de imidazol. - Google Patents

Procedimiento para la preparacion de derivados de imidazol.

Info

Publication number
ES8500056A1
ES8500056A1 ES523709A ES523709A ES8500056A1 ES 8500056 A1 ES8500056 A1 ES 8500056A1 ES 523709 A ES523709 A ES 523709A ES 523709 A ES523709 A ES 523709A ES 8500056 A1 ES8500056 A1 ES 8500056A1
Authority
ES
Spain
Prior art keywords
imidazole derivatives
compounds
preparation
medicines containing
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES523709A
Other languages
English (en)
Other versions
ES523709A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES523709A0 publication Critical patent/ES523709A0/es
Publication of ES8500056A1 publication Critical patent/ES8500056A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE IMIDAZOL Y DE SUS SALES DE ADICION DE ACIDOS FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE A, B, R1, R2 Y R3 PUEDEN SER VARIOS TIPOS DE RADICALES.CONSISTE EN LA REACCION DE CICLIZACION DE UN COMPUESTO, EVENTUALMENTE PREPARADO IN SITU, DE FORMULA (II), EN LA QUE X O Y ES HIDROGENO Y EL OTRO O AMBOS SON UN RADICAL DE FORMULA (III), DONDE Z1 Y Z2 PUEDEN SER VARIOS RADICALES Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA CICLIZACION SE EFECTUA EN UN DISOLVENTE A UNA TEMPERATURA ENTRE 0J Y 250J.ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU EFECTO SOBRE LA CONTRACTILIDAD DEL MUSCULO CARDIACO.
ES523709A 1982-07-01 1983-06-30 Procedimiento para la preparacion de derivados de imidazol. Expired ES8500056A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823224512 DE3224512A1 (de) 1982-07-01 1982-07-01 Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES523709A0 ES523709A0 (es) 1984-10-01
ES8500056A1 true ES8500056A1 (es) 1984-10-01

Family

ID=6167285

Family Applications (3)

Application Number Title Priority Date Filing Date
ES523709A Expired ES8500056A1 (es) 1982-07-01 1983-06-30 Procedimiento para la preparacion de derivados de imidazol.
ES529175A Granted ES529175A0 (es) 1982-07-01 1984-01-26 Procedimiento para la preparacion de derivados de imidazol
ES529174A Expired ES8500241A1 (es) 1982-07-01 1984-01-26 Procedimiento para la preparacion de derivados de imidazol

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES529175A Granted ES529175A0 (es) 1982-07-01 1984-01-26 Procedimiento para la preparacion de derivados de imidazol
ES529174A Expired ES8500241A1 (es) 1982-07-01 1984-01-26 Procedimiento para la preparacion de derivados de imidazol

Country Status (23)

Country Link
US (2) US4582837A (es)
EP (1) EP0098448A3 (es)
JP (1) JPS5927875A (es)
KR (1) KR840005432A (es)
AU (1) AU1642883A (es)
CS (1) CS254319B2 (es)
DD (1) DD210271A5 (es)
DE (1) DE3224512A1 (es)
DK (1) DK301383A (es)
ES (3) ES8500056A1 (es)
FI (1) FI832022L (es)
GB (1) GB2122995B (es)
GR (1) GR78598B (es)
HU (1) HU192152B (es)
IL (1) IL69111A0 (es)
NO (1) NO832356L (es)
NZ (1) NZ204766A (es)
PH (1) PH20810A (es)
PL (2) PL144589B1 (es)
PT (1) PT76968B (es)
SU (2) SU1316559A3 (es)
YU (1) YU143283A (es)
ZA (1) ZA834777B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
US4758574A (en) * 1982-05-03 1988-07-19 Eli Lilly And Company 2-phenylimidazio (4,5-c) pyridines
DE3324115A1 (de) * 1983-07-05 1985-01-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3346575A1 (de) * 1983-12-23 1985-07-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzimidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
ZA851236B (en) * 1984-02-24 1986-09-24 Lilly Co Eli 2-arylimidazo 4,5-cpyridines
PL144822B1 (en) * 1984-05-12 1988-07-30 Boehringer Mannheim Gmbh Method of obtaining novel pyrolobenzimidazoles
EP0178413A1 (en) * 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazoles
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
DE3445299A1 (de) * 1984-12-12 1986-06-19 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3445669A1 (de) * 1984-12-14 1986-06-19 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3522230A1 (de) * 1985-06-21 1987-01-02 Thomae Gmbh Dr K Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
NZ217755A (en) * 1985-10-09 1989-08-29 Chemie Linz Ag 2-(2-thienyl)-imidazo(4,5-c)pyridine derivatives and pharmaceutical compositions
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
US5466704A (en) * 1991-02-26 1995-11-14 E. R. Squibb & Sons, Inc. N-substituted imidazole and benzimidazole derivatives useful as angiotenson II antagonists
FR2677020B1 (fr) * 1991-05-31 1993-08-27 Cird Galderma Composes derives de benzimidazole, leur procede de preparation et leur utilisation dans les domaines therapeutique et cosmetique.
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6919366B2 (en) * 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
EE200100323A (et) 1998-12-18 2002-08-15 Axys Pharmaceuticals, Inc. (Hetero)arüüli - bitsüklilise heteroarüüli derivaadid, nende valmistamine ja nende kasutamine proteaasiinhibiitoritena
GB9914825D0 (en) * 1999-06-24 1999-08-25 Smithkline Beecham Spa Novel compounds
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
DE10015866A1 (de) * 2000-03-30 2001-10-11 Bayer Ag Aryl- und Heteroarylsulfonate
EP1294718A2 (en) * 2000-06-14 2003-03-26 Warner-Lambert Company Llc 6,5-fused bicyclic heterocycles
BR0208010A (pt) 2001-03-12 2004-12-21 Avanir Pharmaceuticals Composto de benzimidazol para modulação de ige e inibição de proliferação celular
JP4416111B2 (ja) * 2002-02-14 2010-02-17 塩野義製薬株式会社 ２，３−ジアミノピリジン誘導体の製造方法
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
WO2004024655A2 (en) 2002-09-12 2004-03-25 Avanir Pharmaceuticals Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
TWI276631B (en) * 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2004263190A1 (en) * 2003-08-08 2005-02-17 Avanir Pharmaceuticals Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US20090149452A1 (en) * 2005-07-01 2009-06-11 Nippon Chemiphar Co., Ltd. Xanthine oxidase inhibitor
JP5175730B2 (ja) * 2005-08-15 2013-04-03 アイアールエム・リミテッド・ライアビリティ・カンパニー Ｔｐｏ模倣剤としての化合物および組成物
WO2008067426A1 (en) * 2006-11-30 2008-06-05 Wyeth Process for the synthesis of monosulfated derivatives of substituted benzoxazoles
US7816540B2 (en) * 2007-12-21 2010-10-19 Hoffmann-La Roche Inc. Carboxyl- or hydroxyl-substituted benzimidazole derivatives
US9186361B2 (en) 2013-03-15 2015-11-17 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
WO2014151630A2 (en) 2013-03-15 2014-09-25 Irm Llc Compounds and compositions for the treatment of parasitic diseases
US9296754B2 (en) 2013-03-15 2016-03-29 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
TN2016000253A1 (en) 2013-12-19 2017-10-06 Novartis Ag [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis.
AR099677A1 (es) * 2014-03-07 2016-08-10 Sumitomo Chemical Co Compuesto heterocíclico fusionado y su uso para el control de plagas
US10730872B2 (en) * 2015-11-16 2020-08-04 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing sustitutents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985891A (en) * 1973-02-03 1976-10-12 Boehringer Ingelheim Gmbh 2-Phenyl-imidazo (4,5-b)pyridines and salts thereof
DE2305339C3 (de) * 1973-02-03 1980-05-08 Dr. Karl Thomae Gmbh, 7950 Biberach Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
DE2927988A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 8-phenyl-purine, deren herstellung und deren verwendung als arzneimittel
DE2927987A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 2-alkoxyphenyl-imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine, deren herstellung und deren verwendung als arzneimittel
JPS5721375A (en) * 1980-07-14 1982-02-04 Yamanouchi Pharmaceut Co Ltd 2,6-di-tert-butyl-4-heterocyclic substituted phenolic derivative and its preparation
DE3273461D1 (en) * 1981-08-19 1986-10-30 Merck Patent Gmbh 2-arylimidazopyridines
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.

Also Published As

Publication number Publication date
SU1316559A3 (ru) 1987-06-07
ES529174A0 (es) 1984-10-01
PH20810A (en) 1987-04-24
DK301383A (da) 1984-01-02
PL242770A1 (en) 1986-10-21
HU192152B (en) 1987-05-28
GB2122995A (en) 1984-01-25
PT76968A (de) 1983-07-01
ZA834777B (en) 1985-03-27
PL144589B1 (en) 1988-06-30
NZ204766A (en) 1986-09-10
PL142880B1 (en) 1987-12-31
US4696931A (en) 1987-09-29
NO832356L (no) 1984-01-02
JPS5927875A (ja) 1984-02-14
SU1179924A3 (ru) 1985-09-15
KR840005432A (ko) 1984-11-12
GB2122995B (en) 1986-02-12
EP0098448A2 (de) 1984-01-18
IL69111A0 (en) 1983-10-31
GB8317732D0 (en) 1983-08-03
PT76968B (de) 1986-04-09
FI832022L (fi) 1984-01-02
ES8500242A1 (es) 1984-10-01
EP0098448A3 (de) 1985-04-03
AU1642883A (en) 1984-01-05
DK301383D0 (da) 1983-06-30
ES529175A0 (es) 1984-10-01
YU143283A (en) 1986-06-30
DD210271A5 (de) 1984-06-06
CS254319B2 (en) 1988-01-15
ES8500241A1 (es) 1984-10-01
DE3224512A1 (de) 1984-01-05
ES523709A0 (es) 1984-10-01
US4582837A (en) 1986-04-15
GR78598B (es) 1984-09-27
FI832022A0 (fi) 1983-06-06

Similar Documents

Publication Publication Date Title
ES8500241A1 (es) Procedimiento para la preparacion de derivados de imidazol
ES473451A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
NO174508C (es)
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
IE940326L (en) Benzimidazole derivatives substituted with a radical group¹and their use for inhibiting gastric acid secretion
ES8102561A1 (es) Procedimiento de preparacion de los aril-1 arilsulfonil-4 a amino-propoxi-3 1h pirazoles
DE3173954D1 (en) Use of adenosin derivatives for the manufacture of psychopharmacons
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
PT81860A (en) Process for preparing pyridopyrimidines useful as medicaments
ES8800214A1 (es) Procedimiento para preparar derivados de bencimidazol substituidos
ES477785A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas.
AU1891683A (en) Substituted 1-phenyl-isoquinoline anti-arrythmic agents
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
ES8304978A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
EP0194579A3 (en) 3-pyridylmethylnaphthyl derivatives, process for their preparation and their use as medicaments
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
DE3461375D1 (en) 1-acetonyl-2-(phenylimino)-imidazolidines, their addition salts, their pharmaceutical compositions and their preparation
ZA841418B (en) N-arylpiperazine derivatives
ZA83856B (en) Thiazaspirane derivatives,processes for their preparation,and medicaments
DE3361628D1 (en) Substituted 5-phenylthio-6-amino-pyrimidinones, process for their preparation and their use, and preparations containing these compounds
EP0194580A3 (en) Imidazole derivatives and process for their preparation
ES469840A1 (es) Procedimiento para la obtencion de nuevos derivados de tria-zolotiadiacinas.
ES8704463A1 (es) Procedimiento para preparar 2-(n-alquinil-n-fenilamino)-imidazolinas
AU7971182A (en) Anthranilic acid derivatives
MY102050A (en) Imidazole anologs of mevalonolactone and derivatives thereof